These results suggest that the baseline levels of 11 immune biomarkers identified by multi-parametric flow cytometry correlate with the RFS and 3 of them correlate also with the OS of resected melanoma patients undergoing treatment with peptide-based vaccination and IFN-α (with or without dacarbazine). Here, IFNA2 is linked to melanoma.